Zen-Bio, Inc. Awarded Phase I SBIR for Skeletal Muscle Work
6/13/2007 3:47:46 AM
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--RTP-based Zen-Bio, Inc. a privately held biotech company announced that it was awarded a 12 month $185,000.00 Phase I SBIR grant from the National Institutes of Health. This grant will be used to fund the isolation and culturing of skeletal muscles cells which will be used in the development of a Human Myocytes and Adipocyte Co-culture system.
comments powered by